文献速递肿瘤 PET/CT

儿童霍奇金淋巴瘤患者全身PET/MRI序列工作流程的优化

Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma Patients.
PubMed 文献 · J Nucl Med · 2022-07-14

该研究评估了84例EuroNet-PHL-C2研究患儿来自13个国际PET中心的初始PET/MRI扫描,比较不同全身MRI序列对PET阳性病灶的检出率。结果显示,脂肪抑制T2加权横断面序列检出率最高(淋巴结95%、脾脏62%、骨骼94%、肺83%),且无证据推荐使用对比剂。

要点

  • 脂肪抑制T2加权横断面序列对淋巴结、骨骼和肺病灶检出率最高。
  • 无证据推荐在儿童霍奇金淋巴瘤全身PET/MRI中使用对比剂。
  • 优化序列选择有助于缩短需麻醉幼儿的检查时间。

核心结论

  • 脂肪抑制T2加权横断面序列检出率最高,适合用于淋巴瘤患者的全身PET/MRI精准检查。
  • 无证据推荐使用对比剂。

研究设计与样本

  • 评估84例EuroNet-PHL-C2研究患儿来自13个国际PET中心的初始PET/MRI扫描。
  • 每条可用MRI序列评估5个PET阳性淋巴结;若出现结外受累,另评估2个脾脏病灶、2个骨骼病灶和2个肺部病灶。
  • 检出率计算为各MRI序列中可见、可解剖定位且可测量的病灶数除以病灶总数。

主要发现

  • 脂肪抑制T2加权横断面序列检出率:淋巴结95%、脾脏62%、骨骼94%、肺83%。
  • 非脂肪抑制T2加权横断面序列检出率:淋巴结86%、脾脏49%、骨骼16%、肺59%。
  • 脂肪抑制纵向弛豫时间加权对比增强横断面序列检出率:淋巴结74%、脾脏35%、骨骼57%、肺55%。

临床怎么用

  • 作者认为脂肪抑制T2加权横断面序列检出率最高,适合用于淋巴瘤患者的全身PET/MRI精准检查。
  • 作者认为无证据推荐使用对比剂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

18F-FDG PET/MRI might be the diagnostic method of choice for Hodgkin lymphoma patients, as it combines significant metabolic information from PET with excellent soft-tissue contrast from MRI and avoids radiation exposure from CT. However, a major issue is longer examination times than for PET/CT, especially for younger children needing anesthesia. Thus, a targeted selection of suitable whole-body MRI sequences is important to optimize the PET/MRI workflow. Methods: The initial PET/MRI scans of 84 EuroNet-PHL-C2 study patients from 13 international PET centers were evaluated. In each available MRI sequence, 5 PET-positive lymph nodes were assessed. If extranodal involvement occurred, 2 splenic lesions, 2 skeletal lesions, and 2 lung lesions were also assessed. A detection rate was calculated dividing the number of visible, anatomically assignable, and measurable lesions in the respective MRI sequence by the total number of lesions. Results: Relaxation time-weighted (T2w) transverse sequences with fat saturation (fs) yielded the best result, with detection rates of 95% for nodal lesions, 62% for splenic lesions, 94% for skeletal lesions, and 83% for lung lesions, followed by T2w transverse sequences without fs (86%, 49%, 16%, and 59%, respectively) and longitudinal relaxation time-weighted contrast-enhanced transverse sequences with fs (74%, 35%, 57%, and 55%, respectively). Conclusion: T2w transverse sequences with fs yielded the highest detection rates and are well suited for accurate whole-body PET/MRI in lymphoma patients. There is no evidence to recommend the use of contrast agents.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Georgi TW, Stoevesandt D, Kurch L, et al. Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma Patients. J Nucl Med. 2022. PMID: 35835583. doi:10.2967/jnumed.122.264112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。